Search Results

A healthcare professional in a white coat and stethoscope discusses information on a laptop with an older adult wearing glasses. Receiving a cancer diagnosis and undergoing treatment is an arduous journey filled with hope and resilience. However, even after successful treatment, the fear of cancer recurrence often lingers in the minds of survivors. In this…

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer MOA: Azenosertib inhibits WEE1, accelerating the cell cycle and driving cancer cells with genetic instability or replication stress into apoptosis Key Eligibility Criteria: Histologically or cytologically diagnosed high-grade serous OC/FP/PPC…

Medical professional in a white coat discussing information with another person during a consultation. January is Cervical Cancer Awareness Month, a time to shed light on one of the most common cancers affecting women worldwide. Getting diagnosed with cervical cancer can be overwhelming and life-altering, causing a whirlwind of emotions and questions. In this first…

Kimberly Brice has been a nurse for two decades and has specialized in Oncology for more than five years. Her education credentials include two master’s degrees in nursing with concentrations in Clinical Nurse Specialty and Adult/Gerontology Nurse Practitioner, and a doctoral degree in Nursing Practice with a concentration in Advanced Clinical Practice. Kimberly’s role at…

Group of people sitting together indoors, with one person smiling and engaging with others. The journey of cancer survival is undoubtedly challenging, and the importance of a robust support network cannot be overstated. In this article, we delve into the vital role that friends, family, and support groups play in the recovery and healing process…

CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-high or High risk of Recurrence Who Have Completed Definitive Locoregional…